190 related articles for article (PubMed ID: 31634299)
1. Increasing Rates of Pediatric Empyema and Disease Severity With Predominance of Serotype 3 S. pneumonia: An Australian Single-center, Retrospective Cohort 2011 to 2018.
Haggie S; Fitzgerald DA; Pandit C; Selvadurai H; Robinson P; Gunasekera H; Britton P
Pediatr Infect Dis J; 2019 Dec; 38(12):e320-e325. PubMed ID: 31634299
[TBL] [Abstract][Full Text] [Related]
2. Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine.
Syrogiannopoulos GA; Michoula AN; Tsimitselis G; Vassiou K; Chryssanthopoulou DC; Grivea IN
Infect Dis (Lond); 2016 Oct; 48(10):749-53. PubMed ID: 27320108
[TBL] [Abstract][Full Text] [Related]
3. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.
Byington CL; Korgenski K; Daly J; Ampofo K; Pavia A; Mason EO
Pediatr Infect Dis J; 2006 Mar; 25(3):250-4. PubMed ID: 16511389
[TBL] [Abstract][Full Text] [Related]
4. The changing face of pleural empyemas in children: epidemiology and management.
Schultz KD; Fan LL; Pinsky J; Ochoa L; Smith EO; Kaplan SL; Brandt ML
Pediatrics; 2004 Jun; 113(6):1735-40. PubMed ID: 15173499
[TBL] [Abstract][Full Text] [Related]
5. Laboratory-based, 2-year surveillance of pediatric parapneumonic pneumococcal empyema following heptavalent pneumococcal conjugate vaccine universal vaccination in Madrid.
Picazo J; Ruiz-Contreras J; Casado-Flores J; Negreira S; Del Castillo F; Hernández-Sampelayo T; Bueno M; Calvo C; Ríos E; Méndez C;
Pediatr Infect Dis J; 2011 Jun; 30(6):471-4. PubMed ID: 21266938
[TBL] [Abstract][Full Text] [Related]
6. Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia.
Strachan R; Homaira N; Beggs S; Bhuiyan MU; Gilbert GL; Lambert SB; Macartney K; Marshall H; Martin AC; McCallum GB; McCullagh A; McDonald T; McIntyre P; Oftadeh S; Ranganathan S; Suresh S; Wainwright CE; Wilson A; Wong M; Snelling T; Jaffé A
Thorax; 2021 May; 76(5):487-493. PubMed ID: 33504566
[TBL] [Abstract][Full Text] [Related]
7. Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions/empyema in Germany, 2010-2017: a nationwide surveillance study.
Liese JG; Schoen C; van der Linden M; Lehmann L; Goettler D; Keller S; Maier A; Segerer F; Rose MA; Streng A
Clin Microbiol Infect; 2019 Jul; 25(7):857-864. PubMed ID: 30395932
[TBL] [Abstract][Full Text] [Related]
8. Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010-2015.
Silva-Costa C; Brito MJ; Pinho MD; Friães A; Aguiar SI; Ramirez M; Melo-Cristino J; ;
Emerg Infect Dis; 2018 Jul; 24(7):1307-1314. PubMed ID: 29912700
[TBL] [Abstract][Full Text] [Related]
9. Etiology and Incidence of Pleural Empyema in South African Children.
Zampoli M; Kappos A; Wolter N; von Gottberg A; Verwey C; Mamathuba R; Zar HJ
Pediatr Infect Dis J; 2015 Dec; 34(12):1305-10. PubMed ID: 26267310
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children.
Jayasinghe S; Chiu C; Menzies R; Lehmann D; Cook H; Giele C; Krause V; McIntyre P
Vaccine; 2015 Nov; 33(48):6666-74. PubMed ID: 26519550
[TBL] [Abstract][Full Text] [Related]
11. The increasing incidence of empyema.
Burgos J; Falcó V; Pahissa A
Curr Opin Pulm Med; 2013 Jul; 19(4):350-6. PubMed ID: 23508113
[TBL] [Abstract][Full Text] [Related]
12. Sustained high prevalence of pneumococcal serotype 1 in paediatric parapneumonic empyema in southern Spain from 2005 to 2009.
Obando I; Camacho-Lovillo MS; Porras A; Gandía-González MA; Molinos A; Vazquez-Barba I; Morillo-Gutierrez B; Neth OW; Tarrago D
Clin Microbiol Infect; 2012 Aug; 18(8):763-8. PubMed ID: 21910779
[TBL] [Abstract][Full Text] [Related]
13. Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2-6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands.
Wagenvoort GH; Sanders EA; Vlaminckx BJ; Elberse KE; de Melker HE; van der Ende A; Knol MJ
Vaccine; 2016 Feb; 34(8):1077-85. PubMed ID: 26778420
[TBL] [Abstract][Full Text] [Related]
14. Paediatric empyema in New Zealand: a tale of two cities.
Burton C; Walls T; Price N; Glasgow T; Walker C; Beasley S; Best E
N Z Med J; 2015 May; 128(1415):25-33. PubMed ID: 26117509
[TBL] [Abstract][Full Text] [Related]
15. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine.
Hendrickson DJ; Blumberg DA; Joad JP; Jhawar S; McDonald RJ
Pediatr Infect Dis J; 2008 Nov; 27(11):1030-2. PubMed ID: 18845981
[TBL] [Abstract][Full Text] [Related]
16. Invasive pneumococcal disease in Northern Alberta, not a Red Queen but a dark horse.
Marrie TJ; Tyrrell GJ; Majumdar SR; Eurich DT
Vaccine; 2018 May; 36(21):2985-2990. PubMed ID: 29685595
[TBL] [Abstract][Full Text] [Related]
17. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.
Li ST; Tancredi DJ
Pediatrics; 2010 Jan; 125(1):26-33. PubMed ID: 19948570
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of pneumococcal empyema in adults in the early 21st century.
Burgos J; Lujan M; Falcó V; Sánchez A; Puig M; Borrego A; Fontanals D; Planes AM; Pahissa A; Rello J
Clin Infect Dis; 2011 Aug; 53(3):254-61. PubMed ID: 21765073
[TBL] [Abstract][Full Text] [Related]
19. Change in Pneumococcus Serotypes but not Mortality or Morbidity in Pre- and Post-13-Valent Polysaccharide Conjugate Vaccine Era: Epidemiology in a Pediatric Intensive Care Unit over 10 Years.
Hon KL; Chan KH; Ko PL; Cheung MHY; Tsang KYC; Chan LCN; Chan RWY; Leung TF; Ip M
J Trop Pediatr; 2018 Oct; 64(5):403-408. PubMed ID: 29126217
[TBL] [Abstract][Full Text] [Related]
20. Distribution of Streptococcus pneumoniae serotypes that cause parapneumonic empyema in Turkey.
Ceyhan M; Ozsurekci Y; Gürler N; Ozkan S; Sensoy G; Belet N; Hacimustafaoglu M; Celebi S; Keser M; Dinleyici EC; Alhan E; Baki A; Oner AF; Uzun H; Kurugol Z; Aycan AE; Gurbuz V; Karadag Oncel E; Celik M; Ozkaya Parlakay A
Clin Vaccine Immunol; 2013 Jul; 20(7):972-6. PubMed ID: 23637041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
